CRP and cancer: For example, a prospective study involving 15,828 patients with coronary heart disease showed that after multi-variable adjustments, circulating C-reactive protein (CRP) was not independently associated with an increased risk of adverse cardiovascular events, cancer mortality or all-cause mortality [8, 9].